Study guide

9.4 Medication-Related Action Plan (MAP)

PTCB Medication Therapy Management Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy

2 Chapter 2: Medication Product Knowledge

2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings

3 Chapter 3: Terminology & History Collection

3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM

4 Chapter 4: Medication-Related Problems & Labs

4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM

5 Chapter 5: Adherence Calculations

5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures

6 Chapter 6: Documentation Accuracy Reviews

6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks

7 Chapter 7: Prescribing Errors & Therapy Conflicts

7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems

8 Chapter 8: High-Risk Medications in Older Adults

8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support

9 Chapter 9: MTM Core Elements

9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)

10 Chapter 10: Intervention, Documentation & CMS Rules

10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements

11 Chapter 11: CMR, TMR, Billing & Workflow

11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines

9.4 Medication-Related Action Plan (MAP)

Key Takeaways Explain This Topic AI

The Medication-Related Action Plan (MAP) is a patient-centered document listing actions the patient can take to track progress toward medication-related goals.

MAP items are specific, actionable, and written in plain language; they differ from the pharmacist’s comprehensive clinical care plan maintained in the chart.

Include problems the pharmacy team can address with the patient; items requiring another provider’s exclusive action are handled via intervention/referral—not dumped onto the MAP as if the patient can prescribe.

Technicians format, clarify, schedule reminders, and verify MAP completeness against the agreed plan; pharmacists choose clinical content and patient goals.

Follow-up checks whether MAP actions were completed and whether outcomes improved—linking MAP to the documentation/follow-up core element.

Last updated: August 2026

9.4 Medication-Related Action Plan (MAP)

Quick Answer: The MAP is the patient’s to-do list for medication-related self-management—specific, plain-language actions the patient can complete and track. It is not identical to the pharmacist’s full clinical care plan. Technicians help write clearly and follow up; pharmacists decide which actions belong.

The Medication-Related Action Plan (MAP) is the third APhA/NACDS core element. After the MTR identifies problems and the PMR lists medications, the MAP answers: What will the patient do next?

Purpose of the MAP

The MAP is designed to:

  • Translate MTR findings into patient-owned actions
  • Help patients track progress between visits
  • Reinforce education with a written reminder (not memory alone)
  • Support shared accountability at follow-up (“Did you bring the blood pressure log?”)
  • Empower patients—central to the MTM model’s goals
  • MAP succeeds when… MAP fails when…
  • Actions are specific and doable Items say only “take medicines better”
  • Language matches the patient’s literacy Sig codes and jargon dominate
  • Items align with agreed MTR plan MAP contradicts the PMR or counseling
  • Follow-up checks completion MAP is printed and never mentioned again
  • Patient-Centered Action Items vs. Pharmacist Care Plan

This distinction is a frequent exam and workplace trap.

  • Document Audience Typical content Example
  • MAP Patient Actions the patient can take “Fill the weekly pill organizer every Sunday evening.”

Pharmacist care plan / clinical note Clinician chart Assessment, MRP list, rationale, monitoring, prescriber recommendations “MRP: statin nonadherence due to myalgia; plan: hold therapy, contact PCP regarding alternative; check CK if appropriate.”

What belongs on the MAP

Include actions within the patient’s control and appropriate for self-management support, such as:

  • Using adherence tools (organizers, alarms, med sync pickup dates)
  • Recording home monitoring (BP, weight, blood glucose) and bringing logs
  • Taking a medication at a clarified time relative to meals
  • Reading the updated PMR before the next specialist visit
  • Contacting the pharmacy before running out of a chronic medication
  • Avoiding a specific OTC the pharmacist counseled against (patient behavior change)
  • What usually does not belong as a raw MAP line

“Prescriber will change warfarin dose to X mg” presented as if the patient is responsible for rewriting the prescription

  • Complex differential diagnosis plans
  • Internal billing or Star Ratings tasks for staff

Those clinician/provider actions live in the intervention/referral and documentation elements. The patient may have a related MAP item such as “Keep your INR appointment on Tuesday and bring your medication list,” which is patient-owned.

APhA/NACDS framing (study paraphrase): the MAP focuses on medication-related problems the patient and pharmacist can work on together in a patient-action format; issues that must be referred are handled through intervention/referral pathways rather than pretending the patient can execute a prescriber-only change alone.

Writing High-Quality MAP Items

Use a simple quality test for each line:

  • Who? The patient (or caregiver) is the actor
  • What? Concrete behavior
  • When? Timing or frequency
  • How tracked? Log, checkbox, follow-up date
  • Weak MAP item Stronger MAP item
  • Take medicines better Take atorvastatin 40 mg by mouth every night at bedtime; check it off on the calendar

Watch blood pressure Measure blood pressure at home each morning; write the numbers in the log; bring the log to the follow-up visit in 2 weeks

Be careful with pain pills Do not take ibuprofen or naproxen; for pain, use acetaminophen as labeled on your PMR unless your clinician advises otherwise

Follow up sometime Call the pharmacy on March 10 if you have not received your synchronized refill reminder

Limit the MAP to a manageable number of priorities. Five vague items beat zero items, but two clear high-impact actions often beat eight overwhelming ones—especially for patients with low health literacy or caregiver burnout.

Technician Support Role for the MAP

Technicians are force multipliers when they:

  • Support task Good practice
  • Formatting Convert pharmacist-directed patient actions into plain language on the template
  • Consistency check Ensure MAP drug names/doses match the finalized PMR
  • Completeness QA Confirm each listed action has timing/follow-up cues
  • Logistics Schedule the follow-up visit tied to MAP review; set outreach tasks
  • Teach-back support Ask the patient to repeat the top action in their own words using approved scripts
  • Documentation Record that the MAP was provided and note the next check-in date

Technicians should not invent clinical MAP actions (“add start insulin tomorrow”) without pharmacist direction. If the pharmacist’s note says the patient will monitor weight daily for heart-failure therapy, the technician can help phrase and schedule that item.

  • MAP support checklist
  • Every item is patient-actionable
  • Language is plain and specific
  • Items match MTR priorities selected for patient self-management
  • No silent conflict with the PMR
  • Follow-up date/method attached
  • Patient receives a copy (print or portal) before leaving/hanging up
  • How MAP Fits the Five-Element Loop

Loading diagram... MAP Within the MTM Encounter Loop

  • Realistic MAP Scenarios
  • Scenario A — Adherence tool

MTR finds missed evening doses due to shift work. Pharmacist and patient agree on a phone alarm and pill organizer. MAP: “Set a phone alarm for 6:30 a.m. for metformin; fill the 7-day organizer every Sunday after breakfast.” Technician prints the MAP and schedules a two-week adherence check call.

Scenario B — Monitoring, not prescribing

Pharmacist contacts the prescriber about possible ACE-inhibitor cough alternatives (intervention/referral). MAP for the patient: “Keep taking lisinopril as listed on your PMR until your clinic calls; write down cough symptoms daily; bring notes to your clinic visit Friday.” The MAP does not tell the patient to switch drugs alone.

Scenario C — Weak item repaired

Draft MAP says “Improve diabetes control.” Technician flags vagueness; pharmacist revises to “Check fasting blood sugar each morning and record it; bring the log to the follow-up call on the 15th.”

Scenario D — Role boundary

A technician adds “Stop warfarin today” to the MAP because INR was high last month, without pharmacist review of current labs/orders. That exceeds scope and is unsafe. Escalate abnormal concerns; do not freestyle therapy-stopping MAP lines.

Follow-Up: Closing the Loop on MAP Items

Documentation and follow-up (element five) ask:

Did the patient try the actions?

What barriers appeared?

Did outcomes move (adherence, vitals, symptoms, confirmed therapy changes)?

Does the MAP need revision?

Technicians often perform the outreach logistics : call reminders, document attempt outcomes, update task queues, and prepare the chart for pharmacist reassessment. Unfinished MAP items are not personal failures alone—they are data for the next targeted review.

  • Exam watch-outs
  • MAP ≠ PMR
  • MAP ≠ full clinical care plan
  • Patient-centered actions ≠ technician-invented therapy changes
  • Providing a MAP without follow-up planning weakens the core-elements model

Master these boundaries and you are ready for Chapter 10’s deeper treatment of intervention/referral, documentation standards, and CMS Part D offering rules that surround these core documents in real programs.